Resources

11 Resources for

chinabio today and operational accounting

Subscribe to this listing via:
RSS
Email

BNET Resources

China Medical Reports Positive Results for Ongoing Business: ChinaBio Today submits: As promised earlier, China Medical Technologies CMED released selected Q2 (ended September 30, 2008) results, though a full disclosure, complete with analysts’ call, will wait until December 18. The problem with a full release is reporting issues: China Medical is deciding how to account for its...; Tags: Revenue, Net Income, Seeking Alpha, ChinaBio Today, GAAP, Operational Accounting, Financial Accounting, Finance, China; External links 2008-11-18
Genesis Pharma Reports Improved Q1: ChinaBio Today submits: Genesis Pharmaceuticals Enterprises, Inc. (GNPH.OB) reported that Q1 (ended September 30, 2008) revenues climbed an admirable 66% to $27.6 million, and gross profit rose an even more dramatic 81% to $21.8 million. On a non-GAAP basis, Genesis reported net income of $4.8 million a 50% increase....; Tags: Revenue, Net Income, Seeking Alpha, ChinaBio Today, GAAP, Operational Accounting, Financial Accounting, Finance, China; External links 2008-11-18
China Sky One Expands into Injected Drugs: ChinaBio Today submits: China Sky One Medical CSKI received SFDA approval for two new products. Sodium ferulate by injection, a TCM found in the root of Angelica sinensis, is indicated for cardiovascular disease. The drug inhibits the gathering of hematoblasts and stretches blood vessels in order to protect cardiac...; Tags: Injection, Drug, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance, China Sky One Medical Inc., China; External links 2008-10-31
China Sky One Adds Breast Lesion Drug to Product Portfolio: ChinaBio Today submits: China Sky One Medical CSKI has bought a proprietary breast lesion drug from Harbin Medical University for 10 million RMB ($1.5 million). The drug, which China Sky One and Harbin developed jointly, has completed its Phase I trial. In the more than 10,000 patients enrolled in...; Tags: Drug, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance, China Sky One Medical Inc., China; External links 2008-10-30
WuXi Misses Q3 Forecast, Guides Lower for Year: ChinaBio Today submits: WuXi PharmaTech WX released weaker-than-expected financial Q3 results unaudited and, at the same time, lowered guidance for its full year. The company reduced its forecast for 2009 revenue by $20 to $35 million. The new revenue range is expected to be between $260 and $265 million,...; Tags: Revenue, Seeking Alpha, ChinaBio Today, GAAP, Operational Accounting, Financial Accounting, Finance, China; External links 2008-10-15

China Med Forecasts Increased Revenues for 2009 Despite Low Q3: ChinaBio Today submits: China Medicine Corporation (CHME.OB) said a delay in a provincial bidding system caused its Q3 revenues to fall 17% to $10.5 million. Even though margins rose slightly, the increases were not enough to offset Q3’s lower revenues. As a result, net income dipped 10% to $2...; Tags: Revenue, Net Income, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance, China; External links 2008-11-16
Nine New Drugs for China Sky One: ChinaBio Today submits: China Sky One Medical, Inc. CSKI has obtained the rights to nine new drugs from Shandong Medicine Research & Development Institute, paying 15 million RMB ($2.2 million). The company estimates the nine products will generate $5 million in revenue during 2009. According to China...; Tags: China, Drug, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance, China Sky One Medical Inc.; External links 2008-11-13
Tinayin Reports Higher Revenue and Costs: ChinaBio Today submits: Tianyin Pharmaceutical Co. TPI reported higher results for the first quarter of 2009 fiscal year. Revenues rose 33 % to $9.6 million, while net income increased at a slower pace, rising 11% to $1.8 million. However, because the number of shares outstanding almost doubled to 24.6...; Tags: Revenue, Seeking Alpha, ChinaBio Today, Sales Strategy, Sales Force Management, Operational Accounting, Marketing Research, Sales, Finance, Marketing, China; External links 2008-11-11
Mindray's Q3 Leaves Investors Less Than Pleased: ChinaBio Today submits: On the face of it, the Q3 financial report issued by Mindray Medical International MR was very positive. Revenues were up 94% at $146.5 million and non-GAAP net income climbed a smaller but still respectable 48% to $33.7 million. Nevertheless, Mindray’s stock price suffered in the...; Tags: Revenue, Acquisition, Investor, Seeking Alpha, Mindray, ChinaBio Today, Operational Accounting, Mergers & Acquisitions, GAAP, Financial Accounting, Finance, Investment, Healthcare; External links 2008-11-11
China Pharma Reports Improved Q3, Accounts Receivable Also Up: ChinaBio Today submits: China Pharma Holdings (CPHI.OB) reported its Q3 revenues climbed 52% to $12.61 million and net income was up 38% to $4.25 million, which equates to 10 cents per share fully diluted. Growth...; Tags: Revenue, China, Net Income, Accounts Receivable, Pharmaceutical Company, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance; External links 2008-11-11
American Oriental Books Another Solid Quarter: ChinaBio Today submits: American Oriental Bioengineering AOB announced another solid financial performance in Q3. The company’s revenues rose 62% to $70.6 million, and net income was higher by 38% at $16.5 million or 21 cents per diluted share. According to the company, net income failed to keep pace with...; Tags: Revenue, Net Income, Books, Seeking Alpha, ChinaBio Today, Operational Accounting, Finance, American Oriental Bioengineering Inc., China; External links 2008-11-11